BioNTech SE: BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
BioNTech SE: BioNTech Announces First Quarter 2021 Financial Results and Corporate Update More than 450 million doses of BNT162b2 supplied to 91 countries or territories worldwide as of May 6, 2021 Signed agreements for over 1.8 billion doses of BNT162b2 in 2021 and first contracts signed for periods 2022 and beyond Announced planned expansion of global footprint to Asia with establishment of first regional headquarters for south east Asia in Singapore, including a fully-integrated and state-of-the art mRNA manufacturing facility In oncology, a first-in-human Phase 1 trial started for the n...
Source: finanznachrichten.de